Markets:

Overview

News

Currencies

International

Treasuries

Cel-Sci Corporation Common Stock (NY:CVM)

5.835 +0.685 (+13.30%)

Streaming Delayed Price Updated: 2:19 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cel-Sci Corporation Common Stock

CEL-SCI Releases Video Detailing Recent Phase 3 Findings & its Plans to Seek Immediate Regulatory Approvals

October 24, 2023

From CEL-SCI Corporation

Via Business Wire

5-Year Head & Neck Cancer Survival Increased From 45% to 73% in CEL-SCI’s Target Population, Cutting Risk of Death in Half, as Presented at Leading Cancer Conference ESMO 2023

October 23, 2023

From CEL-SCI Corporation

Via Business Wire

CEL-SCI Readies Its Multikine Manufacturing Facility for Commercial Scale Production

October 19, 2023

From CEL-SCI Corporation

Via Business Wire

Why CEL-SCI (CVM) Shares Are Down 20% ↗

July 18, 2023

CEL-SCI Corporation (NASDAQ: CVM) shares are trading lower by 21.3% to $2.25 Tuesday morning after the company priced its public offering of 2.5 million shares at $2.00 per share.

Via Benzinga

CEL-SCI Files Request With the UK’s MHRA Regarding Path to Approval for Multikine in the Treatment of Head & Neck Cancer

October 05, 2023

From CEL-SCI Corporation

Via Business Wire

CEL-SCI Submits Scientific Advice Filing to European Medicines Agency (EMA) for Multikine in the Treatment of Head & Neck Cancer

September 26, 2023

From CEL-SCI Corporation

Via Business Wire

CEL-SCI Corporation Reports Third Quarter Fiscal 2023 Financial Results

August 11, 2023

From CEL-SCI Corporation

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

July 31, 2023

On Monday, 27 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 28, 2023

Friday's session saw 59 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

July 25, 2023

On Tuesday, 56 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

July 24, 2023

On Monday morning, 70 companies achieved new lows for the year.

Via Benzinga

CEL-SCI Announces Closing of Public Offering

July 20, 2023

From CEL-SCI Corporation

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 18, 2023

Via Benzinga

Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 18, 2023

Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.

Via Benzinga

US Stocks Mixed; Bank of America Tops Q2 Views ↗

July 18, 2023

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 70 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.20% to 34,655.10 while the NASDAQ fell 0.38% to...

Via Benzinga

TDOC Stock Alert: Teladoc Doubles Down on Microsoft AI Partnership ↗

July 18, 2023

Teladoc (TDOC) stock is on the move Tuesday as the company expands its Microsoft (MSFT) AI partnership to enhance Teladoc Health Solo.

Via InvestorPlace

CMG Stock Alert: Chipotle Announces International Expansion Plan ↗

July 18, 2023

Chipotle Mexican Grill (CMG) stock is in the news Tuesday after the restaurant chain announced plans for an international expansion.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 18, 2023

Via Benzinga

Why Is CEL-SCI (CVM) Stock Down 23% Today? ↗

July 18, 2023

CEL-SCI (CVM) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering.

Via InvestorPlace

Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket ↗

July 18, 2023

Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

July 18, 2023

It's time to start off trading for Tuesday with a breakdown of the biggest pre-market stock movers worth watching this morning.

Via InvestorPlace

CEL-SCI Announces Pricing of Public Offering

July 17, 2023

From CEL-SCI Corporation

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 17, 2023

Via Benzinga

CEL-SCI Announces Proposed Public Offering of Common Stock

July 17, 2023

From CEL-SCI Corporation

Via Business Wire

CEL-SCI Concludes Positive Meeting With U.S. FDA Concerning Multikine’s Approval for Head & Neck Cancer

July 14, 2023

From CEL-SCI Corporation

Via Business Wire

CEL-SCI Reports Phase 3 Tumor PD-L1 Biomarker Data Demonstrate Multikine’s Increased Efficacy and Points to Potential for Combination With Checkpoint Inhibitors for Head & Neck Cancer

July 11, 2023

From CEL-SCI Corporation

Via Business Wire

CEL-SCI to Present Novel Data at AHNS 11th International Conference on Head and Neck Cancer—New Patent to Be Filed

June 22, 2023

From CEL-SCI Corporation

Via Business Wire

Why CEL-SCI Shares Are Shooting Higher Today ↗

May 15, 2023

CEL-SCI Corporation (NYSE: CVM) announced that the latest results from its pivotal Phase 3 study of Multikine, a presurgical cancer immunotherapy, were presented at the European Society for...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 15, 2023

Via Benzinga

Histopathology and Tumor Biomarker Analysis Confirm CEL-SCI’s Multikine Significantly Prolonged Overall Survival in Head & Neck Cancer—Phase 3 Data Presented at ESTRO 2023

May 15, 2023

From CEL-SCI Corporation

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.